QUORIT
Explore Solutions

Guided by Science. Clinical Intellect.

TIME FRAMEWORK

TIME:
A Systematic Approach to Wound Assessment

How Do We Know What Is Holding the Wound Back?

A systematic wound assessment helps turn a complex wound into identifiable clinical problems.

T Tissue
I Infection / Inflam.
M Moisture
E Edge
SYSTEMATIC MODEL T • I • M • E ASSESSMENT
TIME Framework four-part matrix showing Tissue bed, Cellular infection resolution, Moisture control, and Advancing edge
TIME Clinical Core
Dynamic Assessment Loop Four interconnected clinical vectors
sync_alt
Standardized Tissue Viability Protocol EVIDENCE-ALIGNED
CLINICAL CONTINUUM

The TIME Approach

01

TISSUE

Identify and remove non-viable or deficient tissue to establish a vascularized bed.

Stage 1: Bed Preparation
02

INFECTION / INFLAMMATION

Control persistent bioburden, biofilms, and excessive destructive protease activity.

Stage 2: Defense Control
03

MOISTURE

Calibrate optimal hydrobalance to prevent peri-wound maceration or tissue desiccation.

Stage 3: Hydrobalance
04

EDGE

Promote centripetal keratinocyte advancement and overcome undermining barriers.

Stage 4: Epithelial Advancement
ASSESS IDENTIFY ADDRESS REASSESS
01 T — TISSUE

What Is in the Wound Bed?

LOOK FOR:
  • Necrotic tissue / eschar
  • Slough
  • Deficient tissue
THE QUESTION

“Is the wound bed ready to heal?”

CLINICAL PURPOSE

Remove barriers and create a viable wound bed.

Different types of debridement are used to restore a viable wound environment.

WOUND BED IDENTIFY NON-VIABLE / DEFICIENT TISSUE CREATE A VIABLE WOUND ENVIRONMENT
layers TISSUE STRATA CUTAWAY NON-GRAPHIC EDUCATIONAL MODEL
Educational diagram showing histological tissue layers, dermo-epidermal junction, and granulation microenvironment
CLICK TO INSPECT CLINICAL PHENOTYPE:

NECROTIC TISSUE / ESCHAR

NON-VIABLE BARRIER

Black, brown, or hardened devitalized tissue adhering firmly to the wound base or margins. Acts as a physical and biological barrier preventing granulation capillary formation, re-epithelialization, and cellular penetration.

info Requires identification for appropriate clinical debridement to restore cellular viability.
02 I — INFECTION / INFLAMMATION

Is the Wound Still in Defense Mode?

Persistent cellular activation and sustained microbial bioburden prevent progression from inflammation to the proliferative phase.

THE QUESTION

“Is inflammation resolving—
or is something keeping it active?”

Differentiating physiological acute response from chronic proteolytic stagnation.
CLINICAL PURPOSE

Identify and address infection, excessive inflammation and microbial factors that may be delaying healing.

Local, systemic or intravenous antimicrobial agents are needed as per clinical features and bacterial bioburden.

Clinical guidance: interventions calibrated strictly to microbiological features.
CELLULAR POLARITY

Microscopic Equilibrium

RESOLVING

Transition toward M2 anti-inflammatory macrophage phenotypes. Down-regulation of active MMPs, allowing newly synthesized fibronectin and type-I collagen fibril assembly.

Advancing toward proliferative granulation trending_up
PERSISTING

Sustained bacterial biofilm colonization and neutrophil extracellular trap release. Continuous enzymatic cleavage of essential growth factor receptors keeps tissue in sterile defense.

Trapped in chronic inflammatory arrest pause_circle
LOOK FOR (5 CLINICAL SIGNALS — CLICK TO EXPAND):
flare expand_more

PERSISTENT INFLAMMATION

coronavirus expand_more

LOCAL / SYSTEMIC SIGNS OF INFECTION

pulse_alert expand_more

INCREASING PAIN OR DETERIORATION

science expand_more

MALODOR / PURULENT EXUDATE

shield expand_more

MICROBIAL BURDEN / BIOFILM

03 M — MOISTURE

Is the Wound Environment Balanced?

Optimal healing occurs within a calibrated moisture window. Both excessive exudate and excessive dryness compromise cellular viability.

INTERACTIVE SCALE

Moisture Continuum

Hover or click any state to calibrate assessment position:

CALIBRATED
BALANCED (OPTIMAL HYDROBALANCE)

Supports cellular signaling, facilitates enzymatic autolysis of fibrinous residues, and provides an ideal fluid medium for growth factors, nutrient delivery, and cell mitosis.

✓ supports healing & cell viability
LOOK FOR (CLINICAL PARAMETERS):
water_drop

Amount of Exudate

None, low, moderate, heavy, or copious.
opacity

Character of Exudate

Serous, haemoserous, sanguineous, purulent.
waves

Maceration

Softened, waterlogged, or white peri-wound margins.
wb_sunny

Excess Dryness

Crusting, scabbing, or desiccation stalling migration.
texture

Peri-Wound Condition

Erythema, excoriation, or fungal satellite lesions.
THE QUESTION

“Does the wound have the right environment for repair?”

Achieving physiological equilibrium between cellular desiccation and destructive maceration.
CLINICAL CONSIDERATION

With exudate management (Foam dressing) and protection of the wound edge being central considerations.

Standard clinical rationale prioritizes dressings that absorb excess fluid while maintaining a moist wound interface.

Objective: protecting the delicate nascent epidermal border from enzymatic degradation.
04 E — EDGE

Is the Wound Actually Moving Toward Closure?

Assessment of epithelial migration margins and surrounding skin integrity to determine whether centripetal closure is progressing.

arrow_downward CENTRIPETAL
→ → → Advancing Edge

Centripetal migration of pink epithelial tissue toward center.

Healthy Centripetal Migration

The epidermal margins are flush with the wound bed, moist, and exhibiting a delicate translucent silvery-pink border representing active keratinocyte mitosis and crawling across a viable collagen matrix.

Clinical Indicator: Confirms reduction in surface perimeter week-over-week.
LOOK FOR:
  • Advancing epithelial edge
  • Non-advancing edge
  • Undermining
  • Condition of surrounding skin
THE QUESTION

“Is new skin moving across the wound—
or has progress stalled?”

Evaluating centripetal epithelial bridge formation over time.
CLINICAL PURPOSE

Identify barriers preventing epithelial advancement and wound closure.

E around non-advancing or undermined wound edges; later descriptions also emphasize the surrounding skin.

CLINICAL CLARITY

TIME Turns Complexity Into Clinical Questions.

A standardized, peer-reviewed framework aligning observation with actionable intervention.

T

TISSUE

“What is in the wound bed?”

Identifies non-viable or deficient extracellular matrix.
I

INFECTION / INFLAMMATION

“Is the wound still in defense mode?”

Detects persistent microbial biofilms & proteases.
M

MOISTURE

“Is the wound environment balanced?”

Calibrates exudate volume & prevents peri-wound breakdown.
E

EDGE

“Is the wound moving toward closure?”

Evaluates keratinocyte advancement & epibole stalling.
CLINICAL CONVERSION

From Assessment to Action

What Did We Find?

ASSESSMENT: T — Tissue WHAT MAY BE PREVENTING PROGRESS?

Non-viable / deficient tissue

ASSESSMENT: I — Infection / Inflammation WHAT MAY BE PREVENTING PROGRESS?

Persistent inflammation / microbial burden

ASSESSMENT: M — Moisture WHAT MAY BE PREVENTING PROGRESS?

Too dry / too wet / uncontrolled exudate

ASSESSMENT: E — Edge WHAT MAY BE PREVENTING PROGRESS?

Non-advancing / undermined wound edge

CONTINUOUS QUALITY CYCLE

Ongoing Clinical Process

A dynamic loop continuously adjusting to wound progression:

01

ASSESS

Systematic TIME evaluation of baseline wound status.

02

IDENTIFY

Pinpoint exact barriers hindering progression.

03

ADDRESS

Deploy tailored therapeutic wound-care solutions.

04

REASSESS

Monitor healing trajectory and iterate clinical strategy.

autorenew REASSESS continuously connects back to ASSESS across the healing continuum.
NEXT CLINICAL MILESTONE

From Assessment
to Appropriate Solutions

Explore the Quorit portfolio after understanding the wound and considering the key factors that may influence its progression.

SCIENTIFIC REFERENCES

Literature supporting structured tissue viability assessment and wound microenvironmental management:

01

Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020.

02

Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015;4(9):560-582.

03

Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020.